


Ask a doctor about a prescription for ENALAPRIL/HYDROCHLOROTHIAZIDE TECNIGEN 20/12.5 mg TABLETS
Package Leaflet: Information for the User
Enalapril/Hydrochlorothiazide TecniGen 20 mg/12.5 mg Tablets EFG
Enalapril Maleate/Hydrochlorothiazide
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
− | Keep this leaflet, you may need to read it again. |
− | If you have any further questions, ask your doctor or pharmacist or nurse. |
− | This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. |
− | If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. |
Contents of the Package Leaflet:
This medicine contains enalapril maleate and hydrochlorothiazide.
The active substance enalapril belongs to a group of medicines called angiotensin-converting enzyme inhibitors (ACE inhibitors), which act by dilating blood vessels to make it easier for the heart to pump blood to all parts of the body.
The active substance hydrochlorothiazide belongs to a group of medicines known as thiazide diuretics, which make the kidneys remove more water and salts.
Together, enalapril and hydrochlorothiazide help to effectively reduce high blood pressure in cases where one of the components has not produced the desired effect.
Your doctor has prescribed Enalapril/Hydrochlorothiazide for the treatment of your high blood pressure (hypertension).
Do not take Enalapril/Hydrochlorothiazide TecniGen:
If you are not sure, consult your doctor before taking Enalapril/Hydrochlorothiazide.
Warnings and precautions
Consult your doctor, pharmacist or nurse before starting to take Enalapril/Hydrochlorothiazide:
Your doctor may monitor your kidney function, blood pressure, and blood electrolyte levels (such as potassium) at regular intervals.
See also the information under the heading “Do not take Enalapril/Hydrochlorothiazide TecniGen”.
Elderly people
In studies where enalapril and hydrochlorothiazide were taken together, the effect of the medicines and tolerability were similar in young adult patients and elderly patients with high blood pressure.
Children and adolescents
The safety and efficacy of enalapril/hydrochlorothiazide have not been established in this population, and therefore its use is not recommended in children.
Taking Enalapril/Hydrochlorothiazide TecniGen with other medicines:
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In general, Enalapril/Hydrochlorothiazide can be used with other medicines. Your doctor may need to change your dose and/or take other precautions:
To prescribe the correct dose of Enalapril/Hydrochlorothiazide, your doctor needs to know if you are taking other medicines to lower blood pressure, medicines to treat diabetes (including oral antidiabetics or insulin), diuretics, potassium-containing medicines (including dietary salt substitutes), lithium (a medicine used to treat a particular type of depression), tricyclic antidepressants, antipsychotics, sympathomimetic medicines, some medicines used to treat pain or certain types of arthritis, including treatments that contain gold salts, alcohol, anesthetics, non-depolarizing muscle relaxants, barbiturates, narcotics, colestyramine and colestipol resins, digitalis glycosides, corticosteroids, ACTH, laxatives, cytostatics (such as cyclophosphamide, methotrexate), medicines that can increase the QT interval (such as quinidine, procainamide, amiodarone, sotalol), acetylsalicylic acid, thrombolytics and beta-blockers.
Taking Enalapril/Hydrochlorothiazide TecniGen with food, drinks and alcohol:
Enalapril/hydrochlorothiazide can be taken with or without food. Most people take enalapril/hydrochlorothiazide with a glass of water.
Pregnancy, breastfeeding and fertility:
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy:
You should tell your doctor if you think you are pregnant (or might be).
As a general rule, your doctor will advise you to stop treatment with Enalapril/Hydrochlorothiazide before you become pregnant or as soon as you know you are pregnant and take another medicine instead of Enalapril/Hydrochlorothiazide. Enalapril/Hydrochlorothiazide is not recommended at the start of pregnancy and should not be used after the third month of pregnancy, as it may cause serious harm to your baby.
Breastfeeding:
You should tell your doctor if you are breastfeeding or plan to breastfeed. Enalapril/Hydrochlorothiazide is not recommended during breastfeeding.
Driving and using machines:
Individual responses to this medicine may vary. Some side effects reported with Enalapril/Hydrochlorothiazide may affect some patients' ability to drive or operate machinery (see section 4. Possible side effects).
Enalapril/Hydrochlorothiazide contains lactose and sodium:
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
This medicine contains less than 1mmol of sodium (23 mg) per tablet; this is, essentially “sodium-free”.
Interference with diagnostic tests:
If you are to undergo any diagnostic test to assess parathyroid gland function, inform your doctor that you are being treated with Enalapril/Hydrochlorothiazide, as it may alter the results.
Use in athletes:
Athletes are informed that this medicine contains a component that may produce a positive result in doping tests.
Follow exactly the administration instructions indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
Your doctor will decide the appropriate dose, depending on your condition and whether you are taking other medicines.
The recommended dose is 1 or 2 tablets administered once a day. They should be taken preferably with water.
The maximum daily dose is 2 tablets.
Take Enalapril/Hydrochlorothiazide TecniGen every day, exactly as indicated by your doctor. It is very important to continue taking this medicine for the time recommended by your doctor.
Do not change the prescribed dose and do not stop taking the medicine without consulting your doctor.
If you have been taking diuretics before starting treatment, or follow a low-salt diet, your doctor will stop the diuretic 2 or 3 days before starting treatment or reduce the initial dose of this medicine.
If you take more Enalapril/Hydrochlorothiazide TecniGen than you should:
Symptoms:
The most likely symptoms in case of overdose are: dizziness or vertigo due to a sudden or excessive drop in blood pressure, and/or excessive thirst, disorientation, decreased urine production and/or rapid heart rate (tachycardia).
Treatment:
In case of overdose, contact your doctor or pharmacist, or the Toxicology Information Service, Telephone: 91-562 04 20, immediately.
If you forget to take Enalapril/Hydrochlorothiazide TecniGen:
You should take the dose of Enalapril/Hydrochlorothiazide indicated by your doctor as soon as possible, but if it is almost time for the next dose, do not take it. Do not take a double dose to make up for forgotten doses.
Restart taking the medicine as originally indicated.
If you stop taking Enalapril/Hydrochlorothiazide TecniGen
Do not stop treatment with Enalapril/Hydrochlorothiazide unless your doctor tells you to.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
The very frequent adverse effects are blurred vision, dizziness, cough, discomfort (nausea) and weakness.
The frequent adverse effects are hypokalemia, increased cholesterol, increased triglycerides, hyperuricemia, headache, depression, syncope, altered taste, hypotension, orthostatic hypotension, changes in heart rhythm, angina, tachycardia, dyspnea, diarrhea, abdominal pain, skin rash, muscle cramps, chest pain, fatigue, hyperkalemia and increased serum creatinine.
The infrequent adverse effects are anemia (including aplastic and hemolytic anemia), hypoglycemia, hypomagnesemia, gout, confusion, somnolence, insomnia, nervousness, paresthesia, vertigo, decreased libido, tinnitus, flushing, palpitations, myocardial infarction or cerebrovascular accident, possibly secondary to excessive blood pressure reduction in high-risk patients, rhinorrhea, throat irritation, hoarseness, bronchospasm/asthma, ileus, pancreatitis, vomiting, dyspepsia, constipation, anorexia, gastric irritation, dry mouth, peptic ulcer, flatulence, sweating, pruritus, urticaria, alopecia, arthralgia, renal failure, and proteinuria, impotence, general malaise, fever, increased uremia, hyponatremia.
The rare adverse effects are neutropenia, decreased hemoglobin, decreased hematocrit, thrombocytopenia, agranulocytosis, bone marrow depression, leucopenia, pancytopenia, lymphadenopathy and autoimmune diseases, increased blood glucose, abnormal dreams, sleep disorders, paralysis (due to hypokalemia), Raynaud's phenomenon, pulmonary infiltrates, respiratory distress (including pneumonia and pulmonary edema), rhinitis, allergic alveolitis/eosinophilic pneumonia, stomatitis/apthous ulcers, glossitis, hepatic failure, hepatic necrosis (which can be fatal), hepatocellular or cholestatic hepatitis, jaundice, cholecystitis (especially in patients with pre-existing cholelithiasis) multiforme edema, Stevens-Johnson syndrome, exfoliative dermatitis, toxic epidermal necrolysis, purpura, cutaneous lupus erythematosus, erythroderma, pemphigus, oliguria, interstitial nephritis, gynecomastia, increased liver enzymes, increased serum bilirubin.
The very rare adverse effects are hypercalcemia, interstitial angioedema and acute respiratory distress (the signs include severe respiratory distress, fever, weakness and confusion).
The adverse effects of unknown frequency are syndrome of inadequate antidiuretic hormone secretion (SIADH), skin and lip cancer (non-melanoma skin cancer) and decreased vision or eye pain due to increased pressure [possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma].
Rarely, other adverse effects may appear, and some may be serious. Consult your doctor or pharmacist for more detailed information on adverse effects.
Stop taking Enalapril/Hydrochlorothiazide and contact your doctor immediately in the following cases:
You should be aware that black patients have a higher risk of developing this type of reaction to ACE inhibitors.
The initial dose may cause a greater drop in blood pressure than will occur after continued treatment. You may feel faint or dizzy and lying down may help. If this is your case, consult your doctor.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines. Website: www.notificaRAM.es.
By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not store at a temperature above 25 °C.
Do not use this medicine after the expiration date indicated on the packaging. It is indicated as CAD. The expiration date is the last day of the month indicated.
Medicines should not be thrown into wastewater or trash. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of medicines you no longer need. This will help protect the environment.
Composition of Enalapril/Hydrochlorothiazide Tecnigen 20 mg/12.5 mg
The active ingredients are enalapril maleate and hydrochlorothiazide
The other components (excipients) are: microcrystalline cellulose, cornstarch, sodium bicarbonate, magnesium stearate, lactose monohydrate and sodium glycolate starch
Appearance of the Product and Package Contents
The Enalapril/Hydrochlorothiazide Tecnigen 20 mg/12.5 mg tablets are white, round and biconvex. Each package contains 10, 28, 30, 60 or 500 tablets in blister packs. Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer:
Marketing Authorization Holder:
Tecnimede España, Industria Farmacéutica, S.A.
Avda. de Bruselas, 13, 3º D.Edificio América. Polígono Arroyo de la Vega,
28108 Alcobendas, Madrid. Spain
Manufacturer:
Atlantic Pharma – Produções Farmacêuticas, S.A.
Rua da Tapada Grande, n.º 2, Abrunheira, 2710-228 Sintra, Portugal
This medicine is authorized in Portugal under the name Enalapril/Hydrochlorothiazide Farmoz 20/12.5 mg tablets.
Date of the Last Revision of this Prospectus: May 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of ENALAPRIL/HYDROCHLOROTHIAZIDE TECNIGEN 20/12.5 mg TABLETS in November, 2025 is around 1.84 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ENALAPRIL/HYDROCHLOROTHIAZIDE TECNIGEN 20/12.5 mg TABLETS – subject to medical assessment and local rules.